UBS Group Increases Encompass Health (NYSE:EHC) Price Target to $130.00
Encompass Health (NYSE:EHC – Get Free Report) had its target price lifted by equities researchers at UBS Group from $117.00 to $130.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price target indicates a potential upside of 12.16% from the stock’s previous close. […]
